000 01382 a2200397 4500
005 20250517103644.0
264 0 _c20170227
008 201702s 0 0 eng d
022 _a1744-7666
024 7 _a10.1080/14656566.2016.1209486
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaremmani, Icro
245 0 0 _aBuprenorphine dosing choices in specific populations: review of expert opinion.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cSep 2016
300 _a1727-31 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnalgesics, Opioid
_xadministration & dosage
650 0 4 _aBuprenorphine
_xadministration & dosage
650 0 4 _aEurope
650 0 4 _aHumans
650 0 4 _aNarcotic Antagonists
_xadministration & dosage
650 0 4 _aOpioid-Related Disorders
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aRolland, Benjamin
700 1 _aSomaini, Lorenzo
700 1 _aRoncero, Carlos
700 1 _aReimer, Jens
700 1 _aWright, Nat
700 1 _aLittlewood, Richard
700 1 _aKrajci, Peter
700 1 _aAlho, Hannu
700 1 _aD'Agnone, Oscar
700 1 _aSimon, Nicolas
773 0 _tExpert opinion on pharmacotherapy
_gvol. 17
_gno. 13
_gp. 1727-31
856 4 0 _uhttps://doi.org/10.1080/14656566.2016.1209486
_zAvailable from publisher's website
999 _c26189469
_d26189469